| Capecitabine |
EU/1/00/163/002 |
Xeloda, Film coated tablet, 500, mg, Pack: 120 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
288.5 |
57.7 |
346.2 |
4% |
10 |
298.5 |
59.7 |
358.2 |
16% |
25 |
323.5 |
64.7 |
388.2 |
цената е вписана в регистъра на пределните цени с решение НСР-8581/24.03.2016. (в сила 02.05.2016) |
НСР-7125/24.09.2015 |
10.10.2015 |
10.10.2015 |
Заличен |
3127 |
| Capecitabine |
EU/1/00/163/002 |
Xeloda, Film coated tablet, 500, mg, Pack: 120 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
344.7 |
68.94 |
413.64 |
4% |
10 |
354.7 |
70.94 |
425.64 |
16% |
25 |
379.7 |
75.94 |
455.64 |
|
НСР-4289/05.08.2014 |
20.08.2014 |
20.08.2014 |
Неактивен |
3127 |
| Capecitabine |
EU/1/00/163/002 |
Xeloda, Film coated tablet, 500, mg, Pack: 120 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
571.32 |
114.26 |
685.58 |
4% |
10 |
581.32 |
116.26 |
697.58 |
16% |
25 |
606.32 |
121.26 |
727.58 |
протокол 20/23.07.2013 |
КЦ-1878/25.10.2010 |
|
|
Неактивен |
3127 |
| Clozapine |
20130128 |
Xenopalan, Tablet, 25, mg, Pack: 50 |
G. L. Pharma GmbH, Австрия |
Gerot Pharmazeutika GmbH, Arnethgasse 3, 1160 Vienna, Австрия |
5.91 |
1.18 |
7.09 |
7% |
0.41 |
6.32 |
1.26 |
7.58 |
20% |
1.18 |
7.5 |
1.5 |
9 |
промяна на обстоятелства решение НСР-6349/03.06.2015 |
НСР-1205/23.09.2013 |
10.10.2013 |
10.10.2013 |
Активен |
4023 |
| Clozapine |
20130129 |
Xenopalan, Tablet, 100, mg, Pack: 50 |
G. L. Pharma GmbH, Австрия |
Gerot Pharmazeutika GmbH, Arnethgasse 3, 1160 Vienna, Австрия |
21.3 |
4.26 |
25.56 |
6% |
1.28 |
22.58 |
4.52 |
27.1 |
18% |
3.83 |
26.41 |
5.28 |
31.69 |
промяна на обстоятелства решение НСР-6348/03.06.2015 |
НСР-1205/23.09.2013 |
10.10.2013 |
10.10.2013 |
Активен |
4024 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 pre-filled syringe + 2 needles |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
508.75 |
101.75 |
610.5 |
4% |
10 |
518.75 |
103.75 |
622.5 |
16% |
25 |
543.75 |
108.75 |
652.5 |
|
НСР-9038/21.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
3364 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 pre-filled syringe + 2 needles |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
508.75 |
101.75 |
610.5 |
4% |
10 |
518.75 |
103.75 |
622.5 |
16% |
25 |
543.75 |
108.75 |
652.5 |
|
НСР-6837/30.07.2015.; НСР-9038/21.04.2016 |
02.06.2016 |
02.06.2016 |
Неактивен |
3364 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 pre-filled syringe + 2 needles |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
763.13 |
152.63 |
915.76 |
4% |
10 |
773.13 |
154.63 |
927.76 |
16% |
25 |
798.13 |
159.63 |
957.76 |
|
НСР-6837/30.07.2015.; НСР-9039/21.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
3365 |
| Paliperidone |
EU/1/11/672/003 |
XEPLION, Prolonged release suspension for injection, 75, mg, Pack: 1 pre-filled syringe + 2 needles |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
413.35 |
82.67 |
496.02 |
4% |
10 |
423.35 |
84.67 |
508.02 |
16% |
25 |
448.35 |
89.67 |
538.02 |
|
НСР-6837/30.07.2015. |
14.08.2015 |
14.08.2015 |
Активен |
3363 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
508.79 |
101.76 |
610.55 |
4% |
10 |
518.79 |
103.76 |
622.55 |
16% |
25 |
543.79 |
108.76 |
652.55 |
|
НСР-6837/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
3364 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
763.16 |
152.63 |
915.79 |
4% |
10 |
773.16 |
154.63 |
927.79 |
16% |
25 |
798.16 |
159.63 |
957.79 |
|
НСР-6837/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
3365 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
805.88 |
161.18 |
967.06 |
4% |
10 |
815.88 |
163.18 |
979.06 |
16% |
25 |
840.88 |
168.18 |
1009.06 |
|
НСР-5119/21.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3365 |
| Paliperidone |
EU/1/11/672/003 |
XEPLION, Prolonged release suspension for injection, 75, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
459.25 |
91.85 |
551.1 |
4% |
10 |
469.25 |
93.85 |
563.1 |
16% |
25 |
494.25 |
98.85 |
593.1 |
|
НСР-5120/24.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3363 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
565.29 |
113.06 |
678.35 |
4% |
10 |
575.29 |
115.06 |
690.35 |
16% |
25 |
600.29 |
120.06 |
720.35 |
|
НСР-5121/24.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3364 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
565.31 |
113.06 |
678.37 |
4% |
10 |
575.31 |
115.06 |
690.37 |
16% |
25 |
600.31 |
120.06 |
720.37 |
|
НСР-2326/13.01.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
3364 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
844.04 |
168.81 |
1012.85 |
4% |
10 |
854.04 |
170.81 |
1024.85 |
16% |
25 |
879.04 |
175.81 |
1054.85 |
|
НСР-2326/13.01.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
3365 |
| Paliperidone |
EU/1/11/672/003 |
XEPLION, Prolonged release suspension for injection, 75, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
459.27 |
91.85 |
551.12 |
4% |
10 |
469.27 |
93.85 |
563.12 |
16% |
25 |
494.27 |
98.85 |
593.12 |
|
НСР-640/29.07.2013 |
24.09.2013 |
24.09.2013 |
Неактивен |
3363 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
878.29 |
175.66 |
1053.95 |
4% |
10 |
888.29 |
177.66 |
1065.95 |
16% |
25 |
913.29 |
182.66 |
1095.95 |
|
КЦРР-2382/21.02.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
3365 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
675.58 |
135.12 |
810.7 |
4% |
10 |
685.58 |
137.12 |
822.7 |
16% |
25 |
710.58 |
142.12 |
852.7 |
|
КЦРР-2382/21.02.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
3364 |
| Paliperidone |
EU/1/11/672/005 |
XEPLION, Prolonged release suspension for injection, 150, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
1047.03 |
209.41 |
1256.44 |
4% |
10 |
1057.03 |
211.41 |
1268.44 |
16% |
25 |
1082.03 |
216.41 |
1298.44 |
|
КЦ-2736/28.09.2011 |
13.10.2011 |
13.10.2011 |
Неактивен |
3365 |
| Paliperidone |
EU/1/11/672/003 |
XEPLION, Prolonged release suspension for injection, 75, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
516.03 |
103.21 |
619.24 |
4% |
10 |
526.03 |
105.21 |
631.24 |
16% |
25 |
551.03 |
110.21 |
661.24 |
|
КЦ-2740/28.09.2011 |
14.10.2011 |
14.10.2011 |
Неактивен |
3363 |
| Paliperidone |
EU/1/11/672/004 |
XEPLION, Prolonged release suspension for injection, 100, mg, Pack: 1 |
Janssen-Cilag International N.V., Белгия |
Janssen Pharmaceutica N.V., Белгия |
693.03 |
138.61 |
831.64 |
4% |
10 |
703.03 |
140.61 |
843.64 |
16% |
25 |
728.03 |
145.61 |
873.64 |
|
КЦ-2738/28.09.2011 |
13.10.2011 |
13.10.2011 |
Неактивен |
3364 |
| Paroxetine |
20040160 |
XETANOR, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland; Actavis Ltd, Malta; Балканфарма Дупница АД |
4.48 |
0.9 |
5.38 |
7% |
0.31 |
4.79 |
0.96 |
5.75 |
20% |
0.9 |
5.69 |
1.14 |
6.83 |
|
НСР-1209/23.09.2013 |
11.10.2013 |
11.10.2013 |
Активен |
2111 |
| Paroxetine |
II-8821/ 09.04.2004 |
XETANOR, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland; Actavis Ltd, Malta; Балканфарма Дупница АД |
6.86 |
1.37 |
8.23 |
7% |
0.48 |
7.34 |
1.47 |
8.81 |
20% |
1.37 |
8.71 |
1.74 |
10.45 |
|
КЦРР-634/18.05.2012 |
03.06.2012 |
03.06.2012 |
Неактивен |
2111 |
| Paroxetine |
II-8821/09.04.2004 |
XETANOR, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland; Actavis Ltd, Malta; Балканфарма Дупница АД |
8.5 |
1.7 |
10.2 |
9% |
0.77 |
9.27 |
1.85 |
11.12 |
22% |
1.87 |
11.14 |
2.23 |
13.37 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
2111 |